Xcella Biosciences, Inc.
Records under this name other than the patents Xcella Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Showing 1 to 2 of 2 · Back to Xcella Biosciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,603,358 | Combination tumor treatment with an integrin-binding-Fc fusion protein and immune stimulator Formerly held Lapsed on the fee record Ended Mar 31, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 31, 2024 | From the USPTO record |
| US 10,350,266 | Method of treating cancer with a multiple integrin binding Fc fusion protein Formerly held Lapsed on the fee record Ended Jul 16, 2023 · High confidence | Lapsed on the fee record | Ended Jul 16, 2023 | High confidence |